Joseph Bakanas
Foot & Ankle Surgery · Wilmington, DENPI 1558520007
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $872 and has fallen 93.5% since, to $57 in 2024. That places this record below the midpoint for foot & ankle surgery clinicians in DE, where the typical reported total is $3,171.
Across 154 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$634
- Paratek Pharmaceuticals, Inc.$395
- Zimmer Biomet$262
- Smith+Nephew$214
- Amgen$152
- Melinta Therapeutics, LLC$131
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$311%
- Food & beverage$2,74498%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 31 | $634 |
| Paratek Pharmaceuticals, Inc. | 28 | $395 |
| Zimmer Biomet | 8 | $262 |
| Smith+Nephew | 14 | $214 |
| Amgen | 10 | $152 |
| Melinta Therapeutics, LLC | 9 | $131 |
| Stryker | 4 | $107 |
| GRT US Holding, Inc. | 6 | $84 |
| Bioventus LLC | 3 | $75 |
| Integra Lifesciences Corporation | 3 | $60 |
| Johnson & Johnson | 2 | $56 |
| Bsn Medical Inc | 1 | $49 |
| Eclipse Technology Solutions Inc. | 2 | $48 |
| Alfasigma USA, Inc. | 3 | $44 |
| Nabriva Therapeutics, PLC | 3 | $43 |
| KCI USA, Inc. | 2 | $37 |
| Zyla Life Sciences, Inc. | 3 | $36 |
| Nevro Corp. | 2 | $35 |
| Boston Scientific | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $31 |
| Averitas Pharma Inc. | 2 | $29 |
| Next Science LLC | 1 | $25 |
| Journey Medical Corporation | 2 | $25 |
| Abbott | 1 | $25 |
| Merck | 2 | $23 |
| Medtronic | 1 | $22 |
| Anika Therapeutics, Inc. | 1 | $22 |
| Biotissue Holdings Inc. | 1 | $20 |
| Linvatec Corporation | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Kerecis Limited | 1 | $11 |
How this compares
$2,790 in reported general payments places this provider in the 45th percentile of 32 foot & ankle surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Wilmington
- Cody BowersWilmington$14K
- Korey DuboisWilmington$7K
- Katrin HeinemanWilmington$6K
- Katherine PersckyWilmington$6K
- David HaleyWilmington$6K
- Rachel NovickWilmington$5K
- Heather RafalWilmington$4K
- Joseph CiampoliWilmington$2K
- Ginny Rishel HuangWilmington$2K
- Kristina BystrakWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.